Evidence map›Paper›PMID 31969127›Full record

ArticleBMC medical imaging2020

Styliani Mantziari, Anastasia Pomoni, John O Prior, Michael Winiker, Pierre Allemann, Nicolas Demartines, Markus Schäfer

Abstract read
In one paragraph

Article in BMC medical imaging, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Cancer imaging : the official publication of the International Cancer Imaging Society · 2026
    Trial
  2. Radiology and oncology · 2026
    Article
  3. Updated evidence on the accuracy ofQuantitative imaging in medicine and surgery · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Scientific reports · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Preoperative metabolic parameters ofQuantitative imaging in medicine and surgery · 2024
    Article
  13. Article
  14. Article
  15. Association of dynamic contrast-enhanced MRI andEuropean journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology · 2023
    Article
  16. Article
  17. Clinical Utility ofDiagnostics (Basel, Switzerland) · 2023
    Review
  18. Article
  19. PretreatmentNuclear medicine and molecular imaging · 2022
    Article
  20. CanCancers · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Styliani MantziariDepartment of Visceral Surgery, Lausanne University Hospital (CHUV), Rue du Bugnon 46, 1011, Lausanne, Switzerland.ORCID 0000-0003-1315-1898
Anastasia PomoniDepartment of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
John O PriorFaculty of Biology and Medicine, University of Lausanne (UNIL), Lausanne, Switzerland.
Michael WinikerDepartment of Visceral Surgery, Lausanne University Hospital (CHUV), Rue du Bugnon 46, 1011, Lausanne, Switzerland.
Pierre AllemannDepartment of Visceral Surgery, Lausanne University Hospital (CHUV), Rue du Bugnon 46, 1011, Lausanne, Switzerland.
Nicolas DemartinesDepartment of Visceral Surgery, Lausanne University Hospital (CHUV), Rue du Bugnon 46, 1011, Lausanne, Switzerland. demartines@chuv.ch.
Markus SchäferDepartment of Visceral Surgery, Lausanne University Hospital (CHUV), Rue du Bugnon 46, 1011, Lausanne, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlthough

methodsAll patients (n = 86) with esophageal adenocarcinoma or squamous cell cancer operated between 2005 and 2014 were analyzed. Linear regression was used to identify clinico-pathologic features of esophageal cancer associated with the tumor's maximal Standardized Uptake Value (SUV

resultsHigh baseline SUV

conclusionsBaseline

Indexed as

AdenocarcinomaAdultAgedAged, 80 and overCarcinoma, Squamous CellEsophageal NeoplasmsFemaleFluorodeoxyglucose F18GlycolysisHumansMaleMiddle AgedNeoplasm StagingPositron Emission Tomography Computed TomographyPrognosisRadiographic Image Interpretation, Computer-AssistedFluorodeoxyglucose F18Radiopharmaceuticals18FDG PET/CTEsophageal cancerMetabolic imagingNuclear imagingTNM stage

Identifiers

PMID31969127
PMCPMC6977262

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.